相关实验视频
Updated: Jul 26, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.4K
与疾病相关的乙化模式稳定了纤维的形成
Li Li1, Binh A Nguyen1, Vishruth Mullapudi1
1Center for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Structure (London, England : 1993)
|June 22, 2023
概括
氨酸乙化通过稳定相互作用促进氨基胺纤维的组合,揭示了氨酸残留在神经退行性疾病中的双重作用. 这一发现提供了通过向的乙化模式来控制聚的潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- 陶蛋白组装成富含β片的粉样蛋白是各种疾病的核心.
- 氨酸乙化与驱动陶粉样蛋白组合有关,但机制尚不清楚.
研究的目的:
- 阐明 lysine 乙化影响tau 粉样蛋白组合的机制.
- 为了研究乙化介导的聚的结构基础.
主要方法:
- 利用tau碎片来识别促进纤维组装的乙化模式.
- 确定了一个乙化片段纤维的冷电子显微镜 (cryo-EM) 结构.
- 将结构与ex vivo陶病纤维素进行比较.
- 采用基于细胞的测试来评估乙化纤维的活性.
主要成果:
- 确定了特定的乙化模式,侧面是粉胺基因的动机,加速了纤维的组装.
- 冷-EM结构揭示了氨酸乙化如何调解功能获取相互作用.
- 在体外组装纤维和体外陶氏病纤维之间观察到结构上的相似性.
- 在基于细胞的聚合试验中,tau纤维的与疾病相关的乙化模式是活跃的.
结论:
- 氨酸残留物起着双重作用,限制其原始状态的聚合,但在乙化时促进其.
- 乙化稳定了亲聚合相互作用,推动了tau粉样蛋白的形成.
- 酸乙化模式的有针对性的设计可以实现可控的酸聚合和直接折叠到特定的粉样结构中.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
Alzheimer's Disease: Overview
530
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
530

